Neurological effects of elevated levels of angiotensin II in COVID-19 patients.

Khezri, Mohammad Rafi; Ghasemnejad-Berenji, Morteza

Khezri, Mohammad Rafi; Ghasemnejad-Berenji, Morteza.

Khezri MR; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, Sero Road, Urmia, Iran. Drmnkh76@gmail.com.
Ghasemnejad-Berenji M; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, Sero Road, Urmia, Iran.

Hum Cell ; 34(6): 1941-1942, 2021 Nov.

Article in English | MEDLINE | ID: covidwho-1375853

Subject(s)

Angiotensin II/metabolism; COVID-19/metabolism; Cerebral Hemorrhage/etiology; Alzheimer Disease/etiology; Angiotensin-Converting Enzyme 2/metabolism; Blood-Brain Barrier/metabolism; Endocytosis; Humans; Permeability; Receptor, Angiotensin, Type 1/metabolism; SARS-CoV-2/metabolism; SARS-CoV-2/pathogenicity; SARS-CoV-2/physiology

Keywords

Angiotensin II; COVID-19; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Angiotensin II / Cerebral Hemorrhage / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: Hum Cell Year: 2021 Document Type: Article Affiliation country: S13577-021-00605-0

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google